AVITA Medical, Inc.·4

Jun 1, 4:39 PM ET

O'Toole David D 4

Research Summary

AI-generated summary

Updated

AVITA Medical (RCEL) CFO David O'Toole Buys 5,000 Shares via ESPP

What Happened
David D. O'Toole, Chief Financial Officer of AVITA Medical, acquired 5,000 shares of AVITA common stock on May 29, 2026. The shares were purchased under the company's Employee Share Purchase Plan (ESPP) at $3.05 per share for a total reported value of $15,258. This was an acquisition (purchase) rather than a sale.

Key Details

  • Transaction date: 2026-05-29; Price: $3.05 per share; Total value: $15,258.
  • Filing date / accession: Form 4 filed 2026-06-01 (no late-filing flag shown in the provided data).
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnote F1: Shares acquired under the ESPP for the offering period Dec 1, 2025–May 31, 2026; purchase price was 85% of the issuer's closing price on Dec 1, 2025. Transactions were reported as exempt under Rules 16b-3(d) and 16b-3(c).
  • Footnote F2: Reported holdings include unvested restricted stock units (RSUs).

Context
ESPP purchases are routine employee acquisitions made at a discount (here, 85% of the period start closing price) and are treated as exempt compensatory transactions under Rule 16b-3. Such purchases represent insider buying but do not by themselves indicate the insider's future expectations; they reflect participation in the company plan.